童年 朗格汉斯细胞囊血性干涉:与BRAFV600E负载相关的严重程度
Julian Thalhammer1,2, Eric Jeziorski3, Perrine Marec-Bérard1
1Institute of Hematology and Pediatric Oncology, Centre Leon-Berard, Lyon, France.
Blood
|November 1, 2024
概括
兰格汉斯细胞囊细胞症 (LCH) 中的血液学参与 (HI) 可能是轻微或严重的,影响结果和治疗. 严重的HI,由特定的血细胞计值定义,需要集中治疗以获得更好的生存率.
科学领域:
- 儿科血液学 儿科血液学
- 在瘤学瘤学.
- 组织细胞形成研究 组织细胞形成研究
背景情况:
- 血液干扰 (HI) 是儿科朗格汉斯细胞囊细胞症 (LCH) 中的一个关键风险器官表现.
- 已经确立的拉希标准根据血红蛋白,血小板和白细胞数量来定义HI.
- 区分严重程度对于预后和治疗策略至关重要.
研究的目的:
- 分析儿科LCH患者的临床特征,结果和治疗反应.
- 区分轻度HI (MHI) 和严重HI (SHI) 以及它们不同的临床轨迹.
- 评估不断发展的疗法对死亡率和长期并发症的影响.
主要方法:
- 法国国家囊细胞瘤注册局 (1983-2023) 的2313名儿科患者的回顾性分析.
- 根据血红蛋白和血小板数值的输血值,将HI分为MHI和SHI.
- 评估器官参与,实验室参数,突变状态和治疗结果.
主要成果:
- 在331名HI患者中,17%患有巨细胞激活综合征,12%患有神经退行性并发症.
- MHI和SHI的10年生存率显著不同 (分别为98%和73%).
- 随着克拉迪宾-赛塔拉宾和MAPK抑制剂的使用,死亡率下降,有针对性的疗法显示出承诺.
结论:
- 严重的HI,包括关键并发症,保证了风险分层的精细定义.
- 针对性疗法可能更适合SHI,而MHI可以通过常规治疗来管理.
- 需要进一步的研究和临床试验,以优化治疗策略,以治疗不同严重程度的LCHHI.
更多相关视频
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.3K
07:17Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
Published on: August 23, 2024
1.0K
相关概念视频
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
